Savara (SVRA) Tax Rate (2017 - 2018)
Savara (SVRA) reported Tax Rate of 19.21% for Q4 2018, down 1858.0% year-over-year from 1.09% in Q4 2017, and down 2293.1% on a QoQ basis from 0.88% in Q3 2018.
Savara (SVRA) has 2 years of Tax Rate data on file, last reported at 19.21% in Q4 2018.
- Quarterly Tax Rate fell 1858.0% year-over-year to 19.21% in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 3.56% (up 40.0% YoY) and the FY2018 annual result came in at 10.29%, up 321.0% from the prior year.
- Tax Rate retreated to 19.21% in Q4 2018 per SVRA's latest filing, from 0.88% in the prior quarter.
- Across five years, Tax Rate topped out at 14.5% in Q1 2018 and bottomed at 19.21% in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7.07 |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -19.21 |
| Dec 31, 2018 | -19.21 |
| Sep 30, 2018 | 0.88 |
| Sep 30, 2018 | 0.88 |
| Jun 30, 2018 | 2.39 |
| Jun 30, 2018 | 2.39 |
| Mar 31, 2018 | 14.50 |
| Mar 31, 2018 | 14.50 |
| Dec 31, 2017 | -0.63 |
| Dec 31, 2017 | -0.63 |
| Sep 30, 2017 | 1.69 |
| Sep 30, 2017 | 1.69 |
| Jun 30, 2017 | 3.93 |
| Jun 30, 2017 | 3.93 |
| Mar 31, 2017 | 4.55 |
| Mar 31, 2017 | 4.55 |